Oncotarget

Corrections:

Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience

PDF  |  How to cite

Oncotarget. 2017; 8:62817-62817. https://doi.org/10.18632/oncotarget.20632

Metrics: PDF 648 views  |   ?  

Yuan Yuan1, Susan E. Yost1, John Yim3, Yate-Ching Yuan2, Nicola M. Solomon1, Isa Mambetsariev1, Sumanta Pal1, Paul Frankel4, Ravi Salgia1, Susan L. Neuhausen5, Joanne Mortimer1

1 Department of Medical Oncology & Molecular Therapeutics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA
2 Bioinformatics Core Facility, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA
3 Department of Surgery, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA
4 Department of Biostatistics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA
5 Department of Population Sciences, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA

Published: September 05, 2017

This article has been corrected: Dr. John Yim was added to the author list. The authors sincerely apologize for this oversight.

Original article: Oncotarget. 2017;8:26414-23. DOI:https://doi.org/10.18632/oncotarget.14476.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20632